Hot topics close

Eli Lilly commits $5.3B to more Zepbound, Mounjaro production

Eli Lilly commits 53B to more Zepbound Mounjaro production
Boosting production and creating jobs, Eli Lilly invests $5.3 billion in Indiana plants for Zepbound and Mounjaro, with potential label expansion for Zepbound.

Two Eli Lilly manufacturing plants in Indiana are getting a $5.3 billion boost to increase production of Zepbound and Mounjaro, the company said May 24. 

The investment "represents the single largest investment in synthetic medicine [active pharmaceutical ingredient] manufacturing in U.S. history," Eli Lilly's chair and CEO David Ricks said in a news release. 

Leaders of the manufacturing sites in Lebanon, Ind., will hire 200 full-time workers to help increase production. Mounjaro is approved for Type 2 diabetes and Zepbound is indicated for chronic weight management. Eli Lilly is also eyeing a Zepbound label expansion after finding positive results in a sleep apnea trial. 

The announcement raises the company's total investment in the Lebanon site from $3.7 billion to $9 billion. 

Similar shots
News Archive
  • I Have a Dream speech
    I Have a Dream speech
    New Martin Luther King Jr. bobblehead unveiled, recites 'I Have a ...
    16 Jan 2023
    1
  • Monica Rambeau
    Monica Rambeau
    WandaVision: Monica Rambeau Finally Gains Powers | CBR
    19 Feb 2021
    1
  • Virginia Tech basketball
    Virginia Tech basketball
    Virginia Tech basketball: What Mike Young said after UNC win in ACC Tournament semifinals
    13 Mar 2022
    1
  • Will Arnett
    Will Arnett
    Bradley Cooper recalls being ‘addicted to cocaine’ during his twenties
    15 Jun 2022
    1
  • Sherrone Moore
    Sherrone Moore
    Jim Harbaugh Sherrone Moore 'only person' to lead Michigan ESPN
    27 Jan 2024
    8
This week's most popular shots